article thumbnail

Expansion of Pharmaceutical Production Drives Automation Use

Automation World

PMMI research highlights how the pharma industry’s efforts to modernize technology and automate at greater levels are being driven by ongoing supply chain issues and plans to provide more sustainable packaging.

article thumbnail

Emerging Technologies in Pharmaceutical Manufacturing: Modular and Automated Platforms

Frost & Sullivan Manufacturing

In the ever-evolving landscape of pharmaceutical manufacturing, modular and automated platforms are spearheading a transformative shift, particularly in the realm of non-biologics. Robotics streamline procedures, while automation addresses critical challenges such as supply chain disruptions and worker safety.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Telix Pharmaceuticals expands US operations with new acquisition

Manufacturer's Monthly

Image: Buonaventura/stock.adobe.com Australian company, Telix Pharmaceuticals , has come to an agreement to acquire RLS, an American radio pharmacy network that distribute pharamaecutials such as therapeutic radiopharmaceuticals. This is set to furth enabling the delivery of future clinical and commercial radiopharmaceutical products.

article thumbnail

EU regulation lacks consideration of pharmaceutical industry emissions

E&T

The study has described the current regulation of pharmaceutical companies as being unable to prevent the release of chemicals into the environment throughout the manufacturing supply chain. Moreover, in the EU, it is not possible to refuse the marketing authorisation of human pharmaceuticals based on environmental reasons.

article thumbnail

Duchesnay Pharmaceutical Group wins 2024 Life Sciences Innovation Award

Canadian Manufacturing

The award was announced and presented at the ADRIQ gala held November 21 in Montreal and recognizes Duchesnay Pharmaceutical Group’s workplace culture and commitment to pharmaceutical development, as well as its leadership, success and community impact. and around the world.” ” Mr. .”

article thumbnail

DCAT Week 2025: Key Takeaways & Industry Advancements

Frost & Sullivan Manufacturing

Held in New York during March 17-20, 2025, the event focused on pharmaceutical innovation, industry outlook, capacity expansion, and supply chain resilience, driven by the increasing digitization of drug development and manufacturing. Avantor, Inc. trillion in 2024, is expected to grow at a 7% CAGR through 2030.

article thumbnail

API and the University of Alberta break ground on pharmaceutical mfg. facility

Canadian Manufacturing

(Credit: GlobeNewswire) EDMONTON — Construction is set to begin on a pharmaceutical manufacturing facility in the Edmonton Research Park that will provide Canadians with a supply of drugs.